ATEC Alphatec Holdings Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to maximize patient outcomes; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System designed to improve surgical efficiency without compromising accuracy. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; solanas posterior cervico/thoracic fixation system and avalon occipital plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. Further, it develops EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is based in Carlsbad, California.

Recent Analyst Ratings for Alphatec Holdings Inc.

Date	Price Target	Rating	Analyst
6/16/2025	$18.00	Buy	Lake Street
8/1/2024		Overweight → Equal-Weight	Morgan Stanley
7/8/2024	$19.00	Overweight	Barclays
2/9/2024	$26.00	Overweight	Wells Fargo
12/19/2023	$16.00 → $18.00	Buy	Needham
10/20/2023	$22.00	Buy	ROTH MKM
10/12/2022	$12.00	Buy	Jefferies
9/12/2022	$13.00	Overweight	Morgan Stanley
3/2/2022	$22.00 → $17.00	Overweight	Piper Sandler
12/3/2021	$12.50	Neutral	Goldman Sachs

See more ratings

Alphatec Holdings Inc.

Peers

Recent Analyst Ratings for Alphatec Holdings Inc.

Alphatec Holdings Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

CHIEF OPERATING OFFICER Lish Scott sold $251,588 worth of shares (22,727 units at $11.07), decreasing direct ownership by 3% to 748,918 units (SEC Form 4)

Director Woods Ward W Jr was granted 15,131 shares, increasing direct ownership by 11% to 154,291 units (SEC Form 4)

Director Valentine Keith was granted 15,131 shares, increasing direct ownership by 18% to 97,271 units (SEC Form 4)

Director Rydin Jeffrey P was granted 15,131 shares, increasing direct ownership by 3% to 585,441 units (SEC Form 4)

Director Mcginnis Karen K was granted 15,131 shares and sold $47,992 worth of shares (3,963 units at $12.11), increasing direct ownership by 19% to 68,709 units (SEC Form 4)

Director Berkowitz Mortimer Iii was granted 15,131 shares, increasing direct ownership by 2% to 680,550 units (SEC Form 4)

Director Pelizzon David R was granted 15,131 shares, increasing direct ownership by 5% to 346,827 units (SEC Form 4)

Director Blackford Quentin S. was granted 15,131 shares, increasing direct ownership by 3% to 568,369 units (SEC Form 4)

Director Demski David M was granted 15,131 shares, increasing direct ownership by 4% to 429,623 units (SEC Form 4)

EVP, PEOPLE & CULTURE Hunsaker Craig E sold $2,468,278 worth of shares (200,000 units at $12.34), decreasing direct ownership by 12% to 1,450,018 units (SEC Form 4)